Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos

Dominick J. Lemas, Howard W. Wiener, Diane M. O'Brien, Scarlett Hopkins, Kimber Stanhope, Peter J Havel, David B. Allison, Jose R. Fernandez, Hemant K. Tiwari, Bert B. Boyer

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Variants of carnitine palmitoyltransferase 1A (CPT1A), a key hepatic lipid oxidation enzyme, may influence how fatty acid oxidation contributes to obesity and metabolic outcomes. CPT1A is regulated by diet, suggesting interactions between gene variants and diet may influence outcomes. The objective of this study was to test the association of CPT1A variants with body composition and lipids, mediated by consumption of polyunsaturated fatty acids (PUFA). Obesity phenotypes and fasting lipids were measured in a cross-sectional sample of Yup'ik Eskimo individuals (n = 1141) from the Center of Alaska Native Health Research (CANHR) study. Twenty-eight tagging CPT1A SNPs were evaluated with outcomes of interest in regression models accounting for family structure. Several CPT1A polymorphisms were associated with HDL-cholesterol and obesity phenotypes. The P479L (rs80356779) variant was associated with all obesity-related traits and fasting HDL-cholesterol. Interestingly, the association of P479L with HDL-cholesterol was still significant after correcting for body mass index (BMI), percentage body fat (PBF), or waist circumference (WC). Our findings are consistent with the hypothesis that the L479 allele of the CPT1A P479L variant confers a selective advantage that is both cardioprotective (through increased HDL-cholesterol) and associated with reduced adiposity.

Original languageEnglish (US)
Pages (from-to)175-184
Number of pages10
JournalJournal of Lipid Research
Volume53
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Inuits
Carnitine O-Palmitoyltransferase
Genetic Polymorphisms
Body Composition
Polymorphism
Fasting
Genes
Lipids
HDL Cholesterol
Obesity
Chemical analysis
Nutrition
Association reactions
Diet
Phenotype
Oxidation
Adiposity
Waist Circumference
Unsaturated Fatty Acids
Single Nucleotide Polymorphism

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Endocrinology

Cite this

Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos. / Lemas, Dominick J.; Wiener, Howard W.; O'Brien, Diane M.; Hopkins, Scarlett; Stanhope, Kimber; Havel, Peter J; Allison, David B.; Fernandez, Jose R.; Tiwari, Hemant K.; Boyer, Bert B.

In: Journal of Lipid Research, Vol. 53, No. 1, 01.2012, p. 175-184.

Research output: Contribution to journalArticle

Lemas, DJ, Wiener, HW, O'Brien, DM, Hopkins, S, Stanhope, K, Havel, PJ, Allison, DB, Fernandez, JR, Tiwari, HK & Boyer, BB 2012, 'Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos', Journal of Lipid Research, vol. 53, no. 1, pp. 175-184. https://doi.org/10.1194/jlr.P018952
Lemas, Dominick J. ; Wiener, Howard W. ; O'Brien, Diane M. ; Hopkins, Scarlett ; Stanhope, Kimber ; Havel, Peter J ; Allison, David B. ; Fernandez, Jose R. ; Tiwari, Hemant K. ; Boyer, Bert B. / Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos. In: Journal of Lipid Research. 2012 ; Vol. 53, No. 1. pp. 175-184.
@article{39c0037acfcf457c8b17be495caa79f9,
title = "Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos",
abstract = "Variants of carnitine palmitoyltransferase 1A (CPT1A), a key hepatic lipid oxidation enzyme, may influence how fatty acid oxidation contributes to obesity and metabolic outcomes. CPT1A is regulated by diet, suggesting interactions between gene variants and diet may influence outcomes. The objective of this study was to test the association of CPT1A variants with body composition and lipids, mediated by consumption of polyunsaturated fatty acids (PUFA). Obesity phenotypes and fasting lipids were measured in a cross-sectional sample of Yup'ik Eskimo individuals (n = 1141) from the Center of Alaska Native Health Research (CANHR) study. Twenty-eight tagging CPT1A SNPs were evaluated with outcomes of interest in regression models accounting for family structure. Several CPT1A polymorphisms were associated with HDL-cholesterol and obesity phenotypes. The P479L (rs80356779) variant was associated with all obesity-related traits and fasting HDL-cholesterol. Interestingly, the association of P479L with HDL-cholesterol was still significant after correcting for body mass index (BMI), percentage body fat (PBF), or waist circumference (WC). Our findings are consistent with the hypothesis that the L479 allele of the CPT1A P479L variant confers a selective advantage that is both cardioprotective (through increased HDL-cholesterol) and associated with reduced adiposity.",
author = "Lemas, {Dominick J.} and Wiener, {Howard W.} and O'Brien, {Diane M.} and Scarlett Hopkins and Kimber Stanhope and Havel, {Peter J} and Allison, {David B.} and Fernandez, {Jose R.} and Tiwari, {Hemant K.} and Boyer, {Bert B.}",
year = "2012",
month = "1",
doi = "10.1194/jlr.P018952",
language = "English (US)",
volume = "53",
pages = "175--184",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "1",

}

TY - JOUR

T1 - Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos

AU - Lemas, Dominick J.

AU - Wiener, Howard W.

AU - O'Brien, Diane M.

AU - Hopkins, Scarlett

AU - Stanhope, Kimber

AU - Havel, Peter J

AU - Allison, David B.

AU - Fernandez, Jose R.

AU - Tiwari, Hemant K.

AU - Boyer, Bert B.

PY - 2012/1

Y1 - 2012/1

N2 - Variants of carnitine palmitoyltransferase 1A (CPT1A), a key hepatic lipid oxidation enzyme, may influence how fatty acid oxidation contributes to obesity and metabolic outcomes. CPT1A is regulated by diet, suggesting interactions between gene variants and diet may influence outcomes. The objective of this study was to test the association of CPT1A variants with body composition and lipids, mediated by consumption of polyunsaturated fatty acids (PUFA). Obesity phenotypes and fasting lipids were measured in a cross-sectional sample of Yup'ik Eskimo individuals (n = 1141) from the Center of Alaska Native Health Research (CANHR) study. Twenty-eight tagging CPT1A SNPs were evaluated with outcomes of interest in regression models accounting for family structure. Several CPT1A polymorphisms were associated with HDL-cholesterol and obesity phenotypes. The P479L (rs80356779) variant was associated with all obesity-related traits and fasting HDL-cholesterol. Interestingly, the association of P479L with HDL-cholesterol was still significant after correcting for body mass index (BMI), percentage body fat (PBF), or waist circumference (WC). Our findings are consistent with the hypothesis that the L479 allele of the CPT1A P479L variant confers a selective advantage that is both cardioprotective (through increased HDL-cholesterol) and associated with reduced adiposity.

AB - Variants of carnitine palmitoyltransferase 1A (CPT1A), a key hepatic lipid oxidation enzyme, may influence how fatty acid oxidation contributes to obesity and metabolic outcomes. CPT1A is regulated by diet, suggesting interactions between gene variants and diet may influence outcomes. The objective of this study was to test the association of CPT1A variants with body composition and lipids, mediated by consumption of polyunsaturated fatty acids (PUFA). Obesity phenotypes and fasting lipids were measured in a cross-sectional sample of Yup'ik Eskimo individuals (n = 1141) from the Center of Alaska Native Health Research (CANHR) study. Twenty-eight tagging CPT1A SNPs were evaluated with outcomes of interest in regression models accounting for family structure. Several CPT1A polymorphisms were associated with HDL-cholesterol and obesity phenotypes. The P479L (rs80356779) variant was associated with all obesity-related traits and fasting HDL-cholesterol. Interestingly, the association of P479L with HDL-cholesterol was still significant after correcting for body mass index (BMI), percentage body fat (PBF), or waist circumference (WC). Our findings are consistent with the hypothesis that the L479 allele of the CPT1A P479L variant confers a selective advantage that is both cardioprotective (through increased HDL-cholesterol) and associated with reduced adiposity.

UR - http://www.scopus.com/inward/record.url?scp=84455160889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84455160889&partnerID=8YFLogxK

U2 - 10.1194/jlr.P018952

DO - 10.1194/jlr.P018952

M3 - Article

C2 - 22045927

AN - SCOPUS:84455160889

VL - 53

SP - 175

EP - 184

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 1

ER -